Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion description "[Another finding showed that flavopiridol treatment induced a substantial AKT-Ser473 phosphorylation in human glioblastoma T98G cell line in contrast to siRNA-mediated inhibition of Cdk9 and Cdk9 combined with Cdk7, whereas siRNA-mediated silencing of Cdk7 caused a minor increase in AKT-Ser473 phosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion evidence source_evidence_literature NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion SIO_000772 22391209 NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion wasDerivedFrom befree-2016 NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion wasGeneratedBy ECO_0000203 NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- befree-2016 importedOn "2016-02-19" NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.